Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2018

Open Access 01-12-2018 | Study protocol

High flow nasal oxygen after bariatric surgery (OXYBAR), prophylactic post-operative high flow nasal oxygen versus conventional oxygen therapy in obese patients undergoing bariatric surgery: study protocol for a randomised controlled pilot trial

Authors: Rachel Fulton, Jonathan E. Millar, Megan Merza, Helen Johnston, Amanda Corley, Daniel Faulke, Ivan Rapchuk, Joe Tarpey, Philip Lockie, Shirley Lockie, John F. Fraser

Published in: Trials | Issue 1/2018

Login to get access

Abstract

Background

The incidence of obesity is increasing worldwide. In selected individuals, bariatric surgery may offer a means of achieving long-term weight loss, improved health, and healthcare cost reduction. Physiological changes that occur because of obesity and general anaesthesia predispose to respiratory complications following bariatric surgery. The aim of this study is to determine whether post-operative high flow nasal oxygen therapy (HFNO2) improves respiratory function and reduces the incidence of post-operative pulmonary complications (PPCs) in comparison to conventional oxygen therapy in these patients.

Method

The OXYBAR study is a prospective, un-blinded, single centre, randomised, controlled pilot study. Patients with body mass index (BMI) > 30 kg/m2, undergoing laparoscopic bariatric surgery, will be randomised to receive either standard low flow oxygen therapy or HFNO2 in the post-operative period. The primary outcome measure is the change in end expiratory lung impedance (∆EELI) as measured by electrical impedance tomography (EIT). Secondary outcome measures include change in tidal volume (∆Vt), partial arterial pressure of oxygen/fraction of inspired oxygen (PaO2/FiO2) ratio, incidence of PPCs, hospital length of stay and measures of patient comfort.

Discussion

We hypothesise that the post-operative administration of HFNO2 will increase EELI and therefore end expiratory lung volume (EELV) in obese patients. To our knowledge this is the first trial designed to assess the effects of HFNO2 on EELV in this population. We anticipate that data collected during this pilot study will inform a larger multicentre trial.

Trial registration

Australian New Zealand Clinical Trials Registry (ANZCTR), ACTRN12617000694​314. Registered on 15 May 2017.
Appendix
Available only for authorised users
Literature
1.
World Health Organisation. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i–xii. 1–253
2.
Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384(9945):766–81.CrossRefPubMedPubMedCentral
3.
Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham heart study. Circulation. 1983;67(5):968–77.CrossRefPubMed
4.
Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444:840.CrossRefPubMed
5.
Romero-Corral A, Caples SM, Lopez-Jimenez F, Somers VK. Interactions between obesity and obstructive sleep apnea: implications for treatment. Chest. 2010;137(3):711–9.CrossRefPubMedPubMedCentral
6.
Buchmueller TC, Johar M. Obesity and health expenditures: evidence from Australia. Econ Hum Biol. 2015;17:42–58.CrossRefPubMed
7.
Colagiuri S, Lee CM, Colagiuri R, Magliano D, Shaw JE, Zimmet PZ, et al. The cost of overweight and obesity in Australia. Med J Aust. 2010;192(5):260–4.PubMed
8.
Arterburn DE, Fisher DP. The current state of the evidence for bariatric surgery. JAMA. 2014;312(9):898–9.CrossRefPubMed
9.
Angrisani L, Santonicola A, Iovino P, Formisano G, Buchwald H, Scopinaro N. Bariatric surgery worldwide 2013. Obes Surg. 2015;25(10):1822–32.CrossRefPubMed
10.
Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009;13(41):1–190. 215–357, iii-ivCrossRef
11.
Christou NV, Sampalis JS, Liberman M, Look D, Auger S, McLean APH, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240(3):416–24.CrossRefPubMedPubMedCentral
12.
Bamgbade OA, Rutter TW, Nafiu OO, Dorje P. Postoperative complications in obese and nonobese patients. World J Surg. 2007;31(3):556–60.CrossRefPubMed
13.
Baltieri L, Peixoto-Souza FS, Rasera-Junior I, Montebelo MI, Costa D, Pazzianotto-Forti EM. Analysis of the prevalence of atelectasis in patients undergoing bariatric surgery. Braz J Anesth. 2016;66(6):577–82.CrossRef
14.
Mendonca J, Pereira H, Xara D, Santos A, Abelha FJ. Obese patients: respiratory complications in the post-anesthesia care unit. Rev Port Pneumol. 2014;20(1):12–9.CrossRefPubMed
15.
Merkow RP, Bilimoria KY, McCarter MD, Bentrem DJ. Effect of body mass index on short-term outcomes after colectomy for cancer. J Am Coll Surg. 2009;208(1):53–61.CrossRefPubMed
16.
Pizov R. Morbid obesity and postoperative pulmonary atelectasis: an underestimated problem. Surv Anesthesiol. 2003;47(4):227–8.
17.
Brooks-Brunn JA. Predictors of postoperative pulmonary complications following abdominal surgery. Chest. 1997;111(3):564–71.CrossRefPubMed
18.
Mullen JT, Davenport DL, Hutter MM, Hosokawa PW, Henderson WG, Khuri SF, et al. Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery. Ann Surg Oncol. 2008;15(8):2164–72.CrossRefPubMed
19.
Benoist S, Panis Y, Alves A, Valleur P. Impact of obesity on surgical outcomes after colorectal resection. Am J Surg. 2000;179(4):275–81.CrossRefPubMed
20.
Moulton MJ, Creswell LL, Mackey ME, Cox JL, Rosenbloom M. Obesity is not a risk factor for significant adverse outcomes after cardiac surgery. Circulation. 1996;94(9 Suppl):Ii87–92.PubMed
21.
Kelkar KV. Post-operative pulmonary complications after non-cardiothoracic surgery. Ind J Anaesth. 2015;59(9):599–605.CrossRef
22.
Sharp JT, Henry JP, Sweany SK, Meadows WR, Pietras RJ. The total work of breathing in normal and obese men. J Clin Investig. 1964;43(4):728–39.CrossRefPubMed
23.
Zerah F, Harf A, Perlemuter L, Lorino H, Lorino AM, Atlan G. Effects of obesity on respiratory resistance. Chest. 1993;103(5):1470–6.CrossRefPubMed
24.
25.
Hodgson LE, Murphy PB, Hart N. Respiratory management of the obese patient undergoing surgery. J Thoracic Dis. 2015;7(5):943–52.
26.
Behazin N, Jones SB, Cohen RI, Loring SH. Respiratory restriction and elevated pleural and esophageal pressures in morbid obesity. J Appl Physiol (1985). 2010;108(1):212–8.CrossRef
27.
Oppenheimer BW, Berger KI, Segal LN, Stabile A, Coles KD, Parikh M, et al. Airway dysfunction in obesity: response to voluntary restoration of end expiratory lung volume. PLoS One. 2014;9(2):e88015.CrossRefPubMedPubMedCentral
28.
Holley HS, Milic-Emili J, Becklake MR, Bates DV. Regional distribution of pulmonary ventilation and perfusion in obesity. J Clin Investig. 1967;46(4):475–81.CrossRefPubMed
29.
Rivas E, Arismendi E, Agusti A, Sanchez M, Delgado S, Gistau C, et al. Ventilation/perfusion distribution abnormalities in morbidly obese subjects before and after bariatric surgery. Chest. 2015;147(4):1127–34.CrossRefPubMed
30.
Reinius H, Jonsson L, Gustafsson S, Sundbom M, Duvernoy O, Pelosi P, et al. Prevention of atelectasis in morbidly obese patients during general anesthesia and paralysis: a computerized tomography study. Anesthesiology. 2009;111(5):979–87.CrossRefPubMed
31.
ten Brink F, Duke T, Evans J. High-flow nasal prong oxygen therapy or nasopharyngeal continuous positive airway pressure for children with moderate-to-severe respiratory distress? Pediatr Crit Care Med. 2013;14(7):e326–31.CrossRefPubMed
32.
Yoder BA, Stoddard RA, Li M, King J, Dirnberger DR, Abbasi S. Heated, humidified high-flow nasal cannula versus nasal CPAP for respiratory support in neonates. Pediatrics. 2013;131(5):e1482–90.CrossRefPubMed
33.
34.
Spoletini G, Alotaibi M, Blasi F, Hill NS. Heated humidified high-flow nasal oxygen in adults: mechanisms of action and clinical implications. Chest. 2015;148(1):253–61.CrossRefPubMed
35.
Corley A, Caruana LR, Barnett AG, Tronstad O, Fraser JF. Oxygen delivery through high-flow nasal cannulae increase end-expiratory lung volume and reduce respiratory rate in post-cardiac surgical patients. Br J Anaesth. 2011;107(6):998–1004.CrossRefPubMed
36.
Groves N, Tobin A. High flow nasal oxygen generates positive airway pressure in adult volunteers. Aust Crit Care. 2007;20(4):126–31.CrossRefPubMed
37.
Frerichs I, Amato MBP, van Kaam AH, Tingay DG, Zhao Z, Grychtol B, et al. Chest electrical impedance tomography examination, data analysis, terminology, clinical use and recommendations: consensus statement of the Translational EIT Development Study Group. Thorax. 2017;72(1):83–93
38.
Kobylianskii J, Murray A, Brace D, Goligher E, Fan E. Electrical impedance tomography in adult patients undergoing mechanical ventilation: a systematic review. J Crit Care. 2016;35:33–50.CrossRefPubMed
39.
Victorino JA, Borges JB, Okamoto VN, Matos GFJ, Tucci MR, Caramez MPR, et al. Imbalances in regional lung ventilation. Am J Respir Crit Care Med. 2004;169(7):791–800.CrossRefPubMed
40.
Hinz J, Hahn G, Neumann P, Sydow M, Mohrenweiser P, Hellige G, et al. End-expiratory lung impedance change enables bedside monitoring of end-expiratory lung volume change. Intensive Care Med. 2003;29(1):37–43.CrossRefPubMed
41.
Grivans C, Lundin S, Stenqvist O, Lindgren S. Positive end-expiratory pressure-induced changes in end-expiratory lung volume measured by spirometry and electric impedance tomography. Acta Anaesthesiol Scand. 2011;55(9):1068–77.CrossRefPubMed
42.
Bikker IG, Leonhardt S, Bakker J, Gommers D. Lung volume calculated from electrical impedance tomography in ICU patients at different PEEP levels. Intensive Care Med. 2009;35(8):1362–7.CrossRefPubMedPubMedCentral
43.
Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krle AJK, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Rev Panam Salud Publica. 2015;38(6):506–14.PubMedPubMedCentral
44.
ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–7.
45.
Bluth T, Teichmann R, Kiss T, Bobek I, Canet J, Cinnella G, et al. Protective intraoperative ventilation with higher versus lower levels of positive end-expiratory pressure in obese patients (PROBESE): study protocol for a randomized controlled trial. Trials. 2017;18(1):202.CrossRefPubMedPubMedCentral
Metadata
Title
High flow nasal oxygen after bariatric surgery (OXYBAR), prophylactic post-operative high flow nasal oxygen versus conventional oxygen therapy in obese patients undergoing bariatric surgery: study protocol for a randomised controlled pilot trial
Authors
Rachel Fulton
Jonathan E. Millar
Megan Merza
Helen Johnston
Amanda Corley
Daniel Faulke
Ivan Rapchuk
Joe Tarpey
Philip Lockie
Shirley Lockie
John F. Fraser
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Trials / Issue 1/2018
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-018-2777-2

Other articles of this Issue 1/2018

Trials 1/2018 Go to the issue

Study protocol

Topiramate versus naltrexone for alcohol use disorder: study protocol for a genotype-stratified, double-blind randomised controlled trial (TOP study)

Study protocol

Premature ejaculation in primary care: communication strategies versus usual care for male patients consulting for a sexual, urogenital or psychological reason – GET UP: study protocol for a cluster randomised controlled trial

Research

Survey of professional views on sharing interim results by the Data Safety Monitoring Board (DSMB): what to share, with whom and why

Study protocol

Effects of Dangguixu-san on acute lateral ankle sprain: study protocol for a randomized controlled trial

Review

Post-trial follow-up methodology in large randomised controlled trials: a systematic review

Study protocol

Prophylactic antibiotics for the prevention of infection following operative vaginal delivery (ANODE): study protocol for a randomised controlled trial